Alex Lebrun is cofounder and CEO of Nabla. Having raised $17 million in seed funding, they are developing technology that can listen to medical consultations and automatically generate precise, ready-to-use clinical letters. This innovation not only saves doctors valuable time but also ensures more accurate, consistent documentation, potentially improving patient outcomes.

Before launching Nabla, Alex had already established himself as a serial entrepreneur in the AI domain. He previously founded Wit.ai, a natural language platform that was acquired by Facebook, as well as VirtuOz, an AI-driven customer service solution acquired by Nuance in another multi-million-dollar deal. Drawing on his extensive background, Alex shares the strategic decisions and product development insights that allowed him to evolve from these earlier ventures into a technology that addresses critical needs in healthcare.

In our conversation, we delve into how Nabla’s system was engineered—from the algorithms that convert speech to text and structure clinical data to the workflow integrations designed to fit seamlessly into a doctor’s routine. Alex outlines the startup’s core use cases, including note-taking in primary care settings and specialized fields where detailed documentation is essential. Beyond immediate applications, he provides a thoughtful perspective on how machine learning can help transform medicine more broadly, enabling more personalized care, better patient engagement, and even aiding in complex diagnostic support down the line.

Whether you’re fascinated by AI’s potential in healthcare, curious about building a transformative medical technology company from the ground up, or eager to understand the lessons learned from successful exits to industry giants, this episode offers a comprehensive look at the present and future of AI in medicine.

Alex Lebrun Twitter: @lxbrun